What Is Malignant Peripheral Nerve Sheath Tumor?
Source: Genetic and Rare Diseases (GARD) Information Center
You can contact us here
Malignant Peripheral Nerve Sheath Tumor
MPNST, Malignant schwannoma, Neurofibrosarcoma, Neurosarcoma
A malignant peripheral nerve sheath tumor (MPNST) is a rare, aggressive tumor that develops in the protective lining that covers the peripheral nerves — nerves that send messages from the brain and spinal cord to the rest of the body. Learn what causes MPNST and how it's diagnosed and treated.
Central and Peripheral Nervous System
Image by TheVisualMD
Neurofibromatosis type I
Source: Genetic and Rare Diseases (GARD) Information Center
Illustration of rare disease incidence
Image by mcmurryjulie/Pixabay
Sarcomas are rare cancers and MPNST is a rare type of sarcoma, making up 5% to 10% of sarcoma cases.
MPNST is most common in young adults and middle-aged adults. MPNST is more common in people with a genetic condition called neurofibromatosis type 1 (NF1). About 25% to 50% of people with MPNST have NF1. And about 8% to 13% of people with NF1 will get MPNST in their lifetime.
Source: National Cancer Institute (NCI)
Sagittal T1 MRI. Neurofibromatosis type 1, bone dysplasia, partial destruction of the clivus and spinal cord compression
Image by Griselda Ramírez/Wikimedia
MPNST forms when the sheath cells that cover nerves grow and divide more than normal. The fact that almost half of MPNSTs occur in people with neurofibromatosis type 1 may give scientists some clues. Scientists are always working to understand how cancer forms, but it can be hard to prove.
Source: National Cancer Institute (NCI)
Inheritance and Family Medical History
Image by mcmurryjulie
In rare cases, members of the same family may have MPNST. People who have NF1 plus a family history of MPNST may be more likely to get MPNST.
Source: National Cancer Institute (NCI)
Cancer Imaging
Image by TheVisualMD
Some people with MPNST do not have symptoms at first. Later, when the tumor gets larger, symptoms can include:
Imaging: If you have symptoms of MPNST your doctor will use scans such as MRI, CT, and PET to see where the tumor is and how big it is. They will also check for signs that the tumor has spread to other parts of the body.
Biopsy: To check if the tumor is MPNST your doctor will do a biopsy, taking a small sample from the tumor with a needle. An expert, called a pathologist, will study cells from the sample under the microscope and run other tests to see what kind of tumor it is.
Source: National Cancer Institute (NCI)
Surgery
Image by Staff Sgt. Miguel Lara/Wikimedia
Surgery: Once MPNST is diagnosed, you may have surgery to remove the tumor and surrounding tissue. But sometimes surgery is not an option. In that case, your doctor will discuss other options with you.
Radiation therapy: Radiation therapy can be used before and after surgery.
Chemotherapy: If the tumor can’t be safely removed by surgery, chemotherapy can be used to shrink it and make it easier to remove. Sometimes chemotherapy is used with radiation. Chemotherapy can also be used when MPNST has spread to other parts of the body.
It is important to talk with a team of specialists to decide the right treatment for you. You can contact MyPART for help finding experts near you.
Source: National Cancer Institute (NCI)
Prognosis Icon
Image by mcmurryjulie/Pixabay
The estimate of how a disease will affect you long-term is called prognosis. Each person is different and prognosis will depend on many factors, such as:
If you want information on your prognosis, it is important to talk to your doctor. Also, NCI has resources to help you understand cancer prognosis.
The five-year survival rate for people with MPNST is between 23% and 69%. How long someone with MPNST lives depends on the size of the tumor and where it is in the body. People with smaller tumors tend to live longer than people whose cancer has spread to other parts of the body.
It is very important to work with a team of experts as soon as possible after diagnosis to improve your chances of survival. You can contact MyPART for help connecting with experts in MPNST.
Source: National Cancer Institute (NCI)
Get free access to in-depth articles and track your personal health.
Send this HealthJournal to your friends or across your social medias.